Cancer

World-renowned, multidisciplinary research to improve patient outcomes and advance the fight against cancer.

Professor Judith Clements's areas of research expertise include prostate cancer, ovarian and breast cancer, biomarkers for cancer progression, Kallikrein proteases and therapeutic targets.

Overview

Our cancer research area combines the activities of multidisciplinary research teams with the aim of improving outcomes for cancer patients.

We operate a strong collaborative research model where molecular and cellular biologists work alongside bioinformaticians, medicinal chemists, surgeons, oncologists and industrial partners to provide a real bench-to-bedside approach to tackling this disease.

Research programs

  • Prostate cancer
  • Breast cancer
  • Ovarian cancer
  • Endometrial cancer
  • Lung cancer
  • Melanoma

Infrastructure

Partnerships

International linkages

  • Canada
  • Ireland
  • USA
  • Hong Kong
  • UK
  • New Zealand

Cross-disciplinary engagement

  • Biology
  • Biochemistry
  • Genomics
  • Bioinformatics
  • Clinical sciences
  • Medical physics
  • Public health
  • Cancer health services

Impact

Evidence of impact

  • Establishment of the multidisciplinary team clinic for advanced prostate cancer
  • Establishment of a Prostate Cancer Clinical Trials Unit at Princess Alexandra Hospital
  • Identification of prognostic biomarkers
  • Therapeutic development programs targeting gene targets including kallikreins, ID2, Daxx, YB-1, GADD45G, Ghrelin, EphB4, PAR2, tocotrienol and CDCP1
  • ihop Program – Improving Health Outcomes for People
  • Novel therapeutic approaches
  • Improved understanding of cancer biology